Background illustration for clinical trials search

Paid Clinical Trials Dover

Discover 265 paid clinical trials in Dover, Delaware. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

for
Breast Neoplasms
Location: Newark DE, Philadelphia PA, Allentown PA, New York NY,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06926868

Phase 2, Phase 3, Recruiting

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

for
Leukemia, Myeloid, Acute
Location: Newark DE, Philadelphia PA, Bethesda MD, New York NY,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06852222

Phase 3, Recruiting

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

for
Breast Neoplasms
Location: Newark DE, York PA, New Brunswick NJ, Jamaica NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07060807

Phase 3, Recruiting

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Location: Newark DE, Media PA, Annapolis MD, Broomall PA,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07144280

Phase 3, Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

for
Advanced Malignant Solid Neoplasm,
Location: Newark DE, Sewell NJ, Media PA, Philadelphia PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT05564377

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

for
Breast Cancer
Location: Newark DE, Annapolis MD, Broomall PA, Baltimore MD,
Sponsor: Agendia

Sex: All

Age: 18+

Code: NCT03053193

Recruiting

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

for
Non-Small Cell Lung Cancer (NSCLC)
Location: Newark DE, Media PA, Sayre PA, Durham NC, Worcester MA,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT05920356

Phase 3, Recruiting

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

for
Classic Follicular Lymphoma,
Location: Newark DE, Baltimore MD, Philadelphia PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06337318

Phase 3, Recruiting

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

for
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,
Location: Newark DE, Easton MD, Wilmington DE, Chadds Ford PA,
Sponsor: NRG Oncology

Sex: Male

Age: 18+

Code: NCT05946213

Phase 3, Recruiting

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

for
Advanced Solid Tumor, Advanced Malignant Neoplasm,
Location: Newark DE, Philadelphia PA, York PA, Fairfax VA,
Sponsor: PMV Pharmaceuticals, Inc

Sex: All

Age: 12+

Code: NCT04585750

Phase 1, Phase 2, Recruiting

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Newark DE, Sewell NJ, Baltimore MD, Philadelphia PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05987241

Phase 2, Phase 3, Recruiting

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

for
Castration Levels of Testosterone,
Location: Newark DE, Ephrata PA, York PA, Washington D.C. DC,
Sponsor: SWOG Cancer Research Network

Sex: Male

Age: 18+

Code: NCT03678025

Phase 3, Recruiting

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

for
Mantle Cell Lymphoma
Location: Newark DE, New York NY, Mineola NY, Richmond VA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 60+

Code: NCT05976763

Phase 3, Recruiting

A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors

for
Solid Tumor
Location: Newark DE, New York NY, Hackensack NJ, Providence RI,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT05584670

Phase 1, Phase 2, Recruiting

Abnormal Connectivity Involving the Social Reciprocity Network in Autism and the Impact of Neurostimulation in Mitigating the Abnormalities

for
Autism Spectrum Disorder
Location: Newark DE
Sponsor: Christiana Care Health Services

Sex: All

Age: 13 - 18

Code: NCT06807684

Recruiting

Vibration Response Imaging (VRI) in Dyspnea Patients Presenting to the ED

for
Dyspnea
Location: Newark DE, Philadelphia PA, New York NY, Bronx NY,
Sponsor: Deep Breeze

Sex: All

Age: 41+

Code: NCT01206621

Recruiting

Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors

for
Advanced Cancer
Location: Newark DE, Baltimore MD, Bethesda MD, Fairfax VA,
Sponsor: Riboscience, LLC.

Sex: All

Age: 18+

Code: NCT05270213

Phase 1, Recruiting

Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

for
Advanced Melanoma
Location: Newark DE, Bethesda MD, Pittsburgh PA, Canton OH,
Sponsor: Eikon Therapeutics

Sex: All

Age: 18+

Code: NCT06697301

Phase 2, Phase 3, Recruiting

Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature

for
Peripheral Vascular Diseases
Location: Newport DE, Philadelphia PA, Washington D.C. DC,
Sponsor: Boston Scientific Corporation

Sex: All

Age: 18+

Code: NCT04674969

Recruiting

Two Year Developmental Follow-up for PREMOD2 Trial (Premature Infants Receiving Milking or Delayed Cord Clamping)

for
Neurodevelopmental Abnormality
Location: Newark DE, Pittsburgh PA, Cincinnati OH, Chicago IL,
Sponsor: Sharp HealthCare

Sex: All

Age: 1 - 3

Code: NCT03476980

Recruiting